SAGE Therapeutics (SAGE)
NASDAQ:SAGE
Holding SAGE?
Track your performance easily

SAGE Therapeutics (SAGE) Technical Analysis

882 Followers

Technical Sentiment

Overall Consensus
Strong Sell
1Bullish
6Neutral
15Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
SAGE Therapeutics’s (SAGE) Moving Averages Convergence Divergence (MACD) indicator is -0.45, suggesting SAGE Therapeutics is a Sell.
SAGE Therapeutics’s (SAGE) 20-Day exponential moving average is 7.93, while SAGE Therapeutics’s (SAGE) share price is $7.59, making it a Sell.
SAGE Therapeutics’s (SAGE) 50-Day exponential moving average is 9.02, while SAGE Therapeutics’s (SAGE) share price is $7.59, making it a Sell.

SAGE Therapeutics (SAGE) Pivot Points

Sep 19, 2024, 08:45 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.99
7.22
7.40
7.63
7.81
8.04
8.22
Fibonacci
7.22
7.38
7.48
7.63
7.79
7.89
8.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

SAGE Therapeutics (SAGE) Moving Averages

Sep 19, 2024, 08:45 PM
Period
Simple
Exponential
MA5
7.55Sell
7.57Sell
MA10
7.57Sell
7.64Sell
MA20
7.90Sell
7.93Sell
MA50
9.31Sell
9.02Sell
MA100
10.50Sell
10.90Sell
MA200
15.89Sell
14.75Sell
SAGE Therapeutics’s (SAGE) 10-Day exponential moving average is 7.64, while SAGE Therapeutics’s (SAGE) share price is $7.59, making it a Sell.
SAGE Therapeutics’s (SAGE) 100-Day exponential moving average is 10.90, while SAGE Therapeutics’s (SAGE) share price is $7.59, making it a Sell.
SAGE Therapeutics’s (SAGE) stock price is $7.59 and SAGE Therapeutics’s (SAGE) 50-day simple moving average is 9.31, creating a Sell signal.
SAGE Therapeutics’s (SAGE) stock price is $7.59 and SAGE Therapeutics’s (SAGE) 100-day simple moving average is 10.50, creating a Sell signal.
SAGE Therapeutics’s (SAGE) stock price is $7.59 and SAGE Therapeutics’s (SAGE) 200-day simple moving average is 15.89, creating a Sell signal.

SAGE Therapeutics (SAGE) Technical Indicators

Sep 19, 2024, 08:45 PM
Name
Value
Implied Action
RSI (14)
39.80
Neutral
STOCH (9,6)
42.23
Neutral
STOCHRSI (14)
35.17
Neutral
MACD (12,26)
-0.45
Sell
ADX (14)
23.25
Neutral
Williams %R
-74.02
Buy
CCI (14)
-60.74
Neutral
ATR (14)
0.44
-
Ultimate Oscillator
49.64
Neutral
ROC
-7.27
Sell
SAGE Therapeutics’s (SAGE) Relative Strength Index (RSI) is 39.80, creating a Neutral signal.
SAGE Therapeutics’s (SAGE) Trend Strength Indicator (ADX) is 23.25, creating a Neutral signal.
SAGE Therapeutics’s (SAGE) Commodity Channel Index (CCI) is -60.74, creating a Neutral signal.
SAGE Therapeutics’s (SAGE) Price Rate of Change (ROC) is -7.27, creating a Sell signal.

FAQ

Is SAGE a Buy, Hold, or Sell?
Based on SAGE’s technical indicators, SAGE is a Strong Sell.
    What is SAGE’s RSI (14)?
    SAGE’s RSI (14) is 39.80, which suggests SAGE is a Neutral.
      What is SAGE’s MACD?
      SAGE’s MACD is -0.45, which suggests SAGE is a Sell.
        What is SAGE’s 5-day moving average?
        SAGE’s 5-day moving average is 7.55, which suggests SAGE is a Sell.
          What is SAGE’s 20-day moving average?
          SAGE 20-day moving average is 7.90, which suggests SAGE is a Sell.
            What is SAGE’s 50-day moving average?
            SAGE’s 50-day moving average is 9.31, which suggests SAGE is a Sell.
              What is SAGE’s 200-day moving average?
              SAGE’s 200-day moving average is 15.89, which suggests SAGE is a Sell.
                What is SAGE’s Williams % R (14)?
                SAGE’s Williams % R (14) is -74.02, which suggests SAGE is a Buy.
                  What is SAGE’s CCI (14)?
                  SAGE’s CCI (14) is -60.74, which suggests SAGE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis